Clinical model of cost of bladder cancer in the elderly.

[1]  Martin L. Brown,et al.  Economic Impact of Cancer in the United States , 2006 .

[2]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[3]  A. Sabichi,et al.  Clinical model of lifetime cost of treating bladder cancer and associated complications. , 2006, Urology.

[4]  Edward Messing,et al.  Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. , 2006, JAMA.

[5]  E. Messing,et al.  Detection of bladder cancer using a point-of-care proteomic assay. , 2005, JAMA.

[6]  Colin B Begg,et al.  Adherence to surveillance among patients with superficial bladder cancer. , 2003, Journal of the National Cancer Institute.

[7]  Marilyn M. Schapira,et al.  Methodological Issues in the Use of Administrative Claims Data to Study Surveillance After Cancer Treatment , 2002, Medical care.

[8]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[9]  Ruth Etzioni,et al.  Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data , 2002, Medical care.

[10]  A. Smith,et al.  Diet and Bladder Cancer: a Meta-analysis of Six Dietary Variables , 2022 .

[11]  L. Kessler,et al.  Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis , 1995, Medical care.

[12]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[13]  J. Jollis,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. , 1993, Journal of clinical epidemiology.

[14]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[15]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[16]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, , 2006 .